[1] v. Bacycr, H.; Kochinke, F.: Ein neues Verfahren zur Durchführung der Kaskadcnplasmapherese. Experimentelle Studien und klinische Anwendung. Biomedizische Techni 28 (1983), 137-144. [2| Eisenhauer, T.; Armstrong, V. W.; Wieland, H.; Fuchs, C.; Schcler, F.; Seidel, D.: Selective removal of low density lipoproteins (LDL) by precipitation at low pH: First clinical application of the HELP System. Klin. Wochenschr. 65 (1987), 161-168. [3] Geigy: Wissenschaftliche Tabellen: Band Physikalische chemie, Blut, Humangenetik und Stoffwechsel von Xenobiotica. Stuttgart, Thieme 1979,122-123. [4] Gofmann, J. W.; Jones, H. B.; Lindgren, F. T.; Lyon, T. P.; Elliott, H. A.; Strisower, B.: Blood lipids and human atherosclerosis. Circulation 2 (1950), 161-178. [5] Löwe, G. D. 0.; Stromberg, P.; Forbes, C. D.; McArdle, B. M.; Lorrimer, A. R.; Prentice, C. R. M.: Increased blood viHcosity nnd f ibrinolytic Inhibitor in typo II hyperprotetnnomln. Lnncet I (l 982), 472-467, [6] Schwerdtfcgor, R,; Kochinke, F,; Schwander, I.; Mielenz, M,; v, Bacycr, H,: Improvement of membrane LDL apheresis by thermofiltration. Progrcss in Artificial Organs1985, Ed. by Nose, Y., Kjellstrand, C, and Ivanovich, P, Cleveland, ISAO Press 1986, 809-812. [7] Stoffel, W,; Borberg, H.; Greve, V,: Application of specific cxtracorporeal removal of low density lipoprotein in familial hypcrcholestcrolaemia. Lancet 2 (1981), 10051007, [8] Wilhelmsen, L.; Svördsudd, K.; Korsan-Bengtsen, K.; Larson, B.; Welin, L.; Tibblin, G.: Fibrinogen äs a risk factor for stroke and myocardial infarction, New Engl.-J. Med. 311 (1986), 501-504. [9] Yokoyama, S.; Hayashi, R.; Satani, M.; Yamamoto, A.: Selective removal of low density lipoprotein by plasmapheresis in familial hypercholesterolaemia. Arteriosclerosis 5 (1985), 613-622.